Interim results of motor-symptom endpoints of an ongoing, open-label study of levodopa-carbidopa intestinal gel in Parkinson's disease patients with severe motor fluctuations

被引：0
|
作者：
Espay, A. J.
Chatamra, K.
Fernandez, H. H.
Standaert, D. G.
Hauser, R. A.
Benesh, J.
Caras, S. D.
Pritchett, Y. L.
Lenz, R. A.
机构：
来源：
MOVEMENT DISORDERS | 2011年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
375
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [21] Continuous intrajejunal levodopa-carbidopa intestinal gel in the treatment of patients with advanced Parkinson's disease - effects on motor symptoms
    Gmitterova, Karin
    Minar, Michal
    Smutny, Milan
    Valkovic, Peter
    ACTIVITAS NERVOSA SUPERIOR REDIVIVA, 2015, 57 (03): : 57 - 62
  • [22] Safety of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease Patients: Interim Results of a US Subset in the DUOGLOBE Observational Study
    Wilcox, C. Mel
    Draganov, Peter
    Jones, Daryl
    Li, Mei
    Kukreja, Pavnit
    Bergmann, Lars
    Peter, Shajan
    Symington, Kenneth
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S1572 - S1573
  • [23] Suicide in Parkinson's Disease Patients Treated With Levodopa-Carbidopa Intestinal Gel
    Zorko, Nika
    Kojovic, Maja
    Flisar, Dusan
    Pirtosek, Zvezdan
    Kramberger, Milica Gregoric
    MOVEMENT DISORDERS, 2015, 30 (10) : 1434 - 1435
  • [24] Long-term safety of levodopa-carbidopa intestinal gel from an ongoing, open-label, phase 3 continued access to treatment study in advanced Parkinson's disease patients
    Rodriguez, R. L.
    Zadikoff, C.
    Espay, A. J.
    Fung, V. S. C.
    Hall, C.
    Robieson, W. Z.
    Chatamra, K.
    Eaton, S.
    Facheris, M. F.
    Benesh, J.
    MOVEMENT DISORDERS, 2016, 31 : S662 - S663
  • [25] Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review
    Wirdefeldt, Karin
    Odin, Per
    Nyholm, Dag
    CNS DRUGS, 2016, 30 (05) : 381 - 404
  • [26] Effect of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients
    Takei, T.
    Uozumi, T.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 742 - 742
  • [27] Levodopa-Carbidopa Intestinal Gel for the Treatment of Motor Fluctuations and Dyskinesia in Patients with Advanced Parkinson's Disease in a 'Real World' Setting: Results of an Interim Analysis of the Multinational Observational Long-term Study DUOGLOBE
    Standaert, David G.
    Aldred, Jason
    Anca-Herschkovitsch, Marieta
    Davis, Thomas L.
    Iansek, Robert
    Kovacs, Norbert
    Siddiqui, Mustafa S.
    Pontieri, Francesco E.
    Simu, Mihaela
    Bergmann, Lars
    Kukreja, Pavnit
    Li, Mei
    Chaudhuri, K. Ray
    NEUROLOGY, 2019, 92 (15)
  • [28] Effect of levodopa-carbidopa intestinal gel on dyskinesia: Design of an open-label, randomized multicenter 12-week study in advanced Parkinson's disease patients
    Antonini, A.
    Poewe, W.
    Standaert, D.
    Zadikoff, C.
    Dubow, S.
    Bergmann, L.
    Hall, C.
    Robieson, W.
    Felipe, V.
    Barbato, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 180 - 180
  • [29] Effect of levodopa-carbidopa intestinal gel on dyskinesia: design of an open-label, randomized multicenter 12-week study in advanced Parkinson's disease patients
    Antonini, Angelo
    Poewe, Werner
    Standaert, David
    Zadikoff, Cindy
    Dubow, Stephanie
    Bergmann, Lars
    Yegin, Ashley
    Hall, Coleen
    Felipe, Vanessa
    Robieson, Weining
    Barbato, Luigi
    NEUROLOGY, 2017, 88
  • [30] Effect of levodopa-carbidopa intestinal gel on dyskinesia: Design of an open-label, randomized multicenter 12-week study in advanced Parkinson's disease patients
    Antonini, A.
    Poewe, W.
    Standaert, D.
    Zadikoff, C.
    Dubow, S.
    Bergmann, L.
    Yegin, A.
    Hall, C.
    Robieson, W.
    Felipe, V.
    Barbato, L.
    MOVEMENT DISORDERS, 2017, 32
12345